PhD Katja Kološa

PhD Katja Kološa
no.: 29297 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
1.03.00  Natural sciences and mathematics  Biology   
1.08.00  Natural sciences and mathematics  Control and care of the environment   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
157.65
A''
0
A'
111.14
A1/2
111.14
CI10
112
CImax
51
h10
5
A1
0.56
A3
0
Data for the last 5 years (citations for the last 10 years) on November 10, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 10  123  100  10 
Scopus 11  136  112  10.18 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  National Institute of Biology  Department of Genetic Toxicology and Cancer Biology 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J7-60117  Degradation of Cyanotoxins Through Cold Plasma Technologies and Toxicological Characterisation of Transformation Products (CyanoCAPtox)   1/1/2025 - 12/31/2027  PhD Martina Štampar   2,005 
2. J1-60016  Mycotoxins and their complex mixtures: relevance for human health hazard from contaminated food   1/1/2025 - 12/31/2027  PhD Matjaž Novak   3,024 
3. O1-60016  Plesnenje hrane: Skupaj do boljšega razumevanja in učinkovitih rešitev (Slovene)   9/1/2025 - 9/30/2026  PhD Matjaž Novak   2,441 
4. J4-50147  Exploring the theranostic potential of aegerolysin-based protein complexes in combating bladder cancer   10/1/2023 - 9/30/2026  PhD Kristina Sepčić   4,143 
5. J2-50047  Plasma-assisted removal of emerging genotoxic contaminants from wastewater   10/1/2023 - 9/30/2026  PhD Martina Modic   2,793 
6. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,790 
7. J1-4395  Development of novel multifunctional metal-oxide-based nanozymes and their toxicological characterisation (NaNoZymSafe)   10/1/2022 - 9/30/2025  PhD Bojana Žegura   2,961 
8. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors   10/1/2022 - 9/30/2025  PhD Andrej Perdih   2,940 
9. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour   10/1/2021 - 12/31/2024  PhD Alja Štern   5,209 
10. J1-3019  Computational and experimental investigation of senescent cells modulation as a new tool to combat age-related diseases   10/1/2021 - 9/30/2024  PhD Jure Borišek   1,837 
11. J1-2465  Advanced 3D cell models: Bridging the gap between in vitro and in vivo experimental systems (hep3DGenTox)   9/1/2020 - 12/31/2023  PhD Bojana Žegura   3,464 
12. J3-2526  Unravelling glioma stem cell niches for novel therapeutic targets in glioblastoma patients   9/1/2020 - 8/31/2023  PhD Cornelis J.F. van Noorden   2,576 
13. J1-8140  Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene)   5/1/2017 - 4/30/2020  PhD Metka Filipič   4,118 
14. J1-6730  Razvoj novih celičnih linij človeških jeter za raziskave genotoksičnosti in karcinogenosti: novo upanje za človekovo zdravje in zaščito laboratorijskih živali (Slovene)   11/1/2014 - 10/31/2017  PhD Metka Filipič   4,469 
15. J1-4247  Dvojna narava matičnih celic v raku in njihova uporaba v zdravljenju (Slovene)   7/1/2011 - 6/30/2014  PhD Tamara Lah Turnšek   5,577 
16. L3-4328  Hipoksična neaktivnost: implikacije za odpoved srca, pljučno insuficienco in prekomerno težo (Slovene)   7/1/2011 - 6/30/2014  PhD Igor Mekjavić   6,264 
17. J3-4259  Priprava in validacija terapevtskih plazmidov brez selekcijskega gena za antibiotično rezistenco za gensko terapijo raka z inducibilnimi in tkivno specifičnimi promotorji (Slovene)   7/1/2011 - 6/30/2014  PhD Maja Čemažar   6,406 
18. J1-2095  Apoptoza tumorskih celic kot tarča kemoterapevtikov (Slovene)   5/1/2009 - 4/30/2012  PhD Tamara Lah Turnšek   1,972 
19. J1-0848  Antikancerogeno delovanje bioaktivnih spojin cianobakterijskega izvora v nasprotju možganskih tumorjev - gliobastomov (Slovene)   2/1/2008 - 1/31/2011  PhD Tamara Lah Turnšek   3,004 
20. L1-0055  Use of mesenchymal stem cells to target gliomas: Risk assessment and evaluation of umbilical cord blood-derived mesenchymal stem cells as new cellular vectors for therapy.   2/1/2008 - 1/30/2011  PhD Irena Zajc   2,171 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2019 - 12/31/2027 PhD Bojana Žegura   3,133 
2. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2015 - 12/31/2018 PhD Tamara Lah Turnšek   3,490 
3. P1-0245  Ekotoksiologija, toksikološka genomika in karcinogeneza (Slovene)   1/1/2009 - 12/31/2014 PhD Tamara Lah Turnšek   3,534 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite